New JAMA study supports 2013 guidelines on statin therapy for patients at cardiovascular risk

New data published in the Journal of the American Medical Association (JAMA) supports 2013 guidelines that redefined eligibility criteria for statin therapy to include patients at risk of cardiovascular disease.

Phillip Greenland and Michael Lauer said in an accompanying editorial: "there is no longer any question as to whether to offer treatment with statins for patients for primary prevention, and there should now be fewer questions about how to treat and in whom." The 2013 guidelines were brought in by the American College of Cardiology (ACC) and the American Heart Association (AHA). Managing high cholesterol has improved since the introduction of the guidelines, which resulted in wider use of statins.

Study on CVD and CAC